Trial Profile
Levosimendan pre-treatment in patients undergoing coronary artery bypass graft surgery: a double-blind, single center, prospective, randomized, placebo-controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2009
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Coronary artery disease; Myocardial ischaemia
- Focus Therapeutic Use
- 08 Mar 2008 New trial record.